Clinical Trial Update: Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 trial update on abaloparatide-solid microstructured transdermal system for postmenopausal osteoporosis shows efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• abaloparatide-solid microstructured transdermal system (abaloparatide)

Snippet

Sponsor: Radius Health, Inc. | Conditions: Postmenopausal Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2023-02-15